Display:
2011
|
Year
|
Title
|
Authors
|
Publication
|
|
2011
|
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation.
|
Majhail NS, Rizzo JD, Lee SJ, Aljurf MD, Atsuta Y, Bonfim CM, Burns LJ, Chaudhri NA, Davies SM, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A
|
Biology of Blood & Marrow Transplantation
|
|
2011
|
The National Marrow Donor Program¿s Symposium on hematopoietic cell transplantation in 2020: a health care resource and infrastructure assessment.
|
MajhaiL NS, Murphy EA, Denzen EM, Ferguson SS, Anasetti C, Bracey A, Burns LJ, Champlin RE, Hubbard N, Markowitz M, Maziarz RT, Medoff E, Neumann J, Schmit-Pokorny K, Weisdorf DJ, Yolin Raley DS, Chell JW, Snyder EL
|
Biology of Blood & Marrow Transplantation
|
|
2011
|
Alternative donor transplantation for aplastic anemia.
|
Eapen M, Horowitz MM
|
American Society of Hematology, Education Program Book 43-46
|
|
2011
|
Marginal models for clustered time-to-event data with competing risks using pseudovalues.
|
Logan BR, Zhang MJ, Klein JP
|
Biometrics 67:1-7
|
|
2011
|
Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network
|
Horwitz EM, Horowitz MM, DiFronzo NL, Kohn DB, Heslop HE
|
Biology of Blood & Marrow Transplantation 17:192-196
|
|
2011
|
Optimization of therapy for severe aplastic anemia based on clinical, biological and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network
|
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH
|
Biology of Blood & Marrow Transplantation 17:291-299
|
|
2011
|
Autologous vs. reduced intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin's lymphoma beyond first complete response or first partial response biology of blood and marrow transplantation
|
Tomblyn MR, Ewell M, Bredeson C, Kahl BS, Goodman SA, Horowitz MM, Vose JM, Negrin RS, Laport GG
|
Biology of Blood & Marrow Transplantation 17:1051-1057
|
|
2011
|
Alternative donor transplantation: results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood grafts.
|
Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine SM, Wingard JR, Aljitawi OS, Cutler CS, Jagasia MH, Ballen KK, Eapen M, O'Donnell PV
|
Blood 118:282-288
|
|
2011
|
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.
|
Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea EP III, Antin JH, Comenzo R, Goodman S, Hari P, Laport GG, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG
|
Lancet Oncology 12:1195-1203
|
|
2011
|
Allogeneic transplant physician and center capacity in the United States
|
Majhail NS, Murphy EA, Omondi NA, Robinett P, Gajewski JL, LeMaistre CF, Rizzo JD
|
Biology of Blood & Marrow Transplantation 17:956-961
|
|
2011
|
World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks.
|
Bochtler W, Maiers M, Bakker JNA, Marsh SGE, Baier D, Hurley CK, Muller CR
|
Bone Marrow Transplantation 46:338-343
|
|
2011
|
Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region, 1984-2007.
|
Ahmed SO, Ghavamzadeh A, Zaidi S, Baldomero H, Pasquini M, Hussain F, Alimoghaddam K, Al Mohareb F, Ayas M, Hamidieh A, Mahmoud H, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M
|
Biology of Blood & Marrow Transplantation 17:1352-1361
|
|
2011
|
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease
|
Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Nigro LL, Ayas M, Purtill D, Boudjedir K, Chaves W, Walters MC, Wagner J, Gluckman E, Rocha V
|
Biology of Blood & Marrow Transplantation 17:1375-1382
|
|
2011
|
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.
|
Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, Brown M, Champlin RE, Garcia-Lopez J, Hattersely G, Koegler G, Laughlin MJ, Michel G, Nabhan SK, Smith FO, Horowitz MM, Gluckman E, Rocha V
|
Lancet Oncology 12:1214-1221
|
|
2011
|
Unrelated hematopoietic stem cell donors as research subjects.
|
King RJ, Confer DL, Greinix HT, Halter J, Horowitz M, Schmidt AH, Costeas P, Shaw B, Egeland T
|
Bone Marrow Transplantation 46:10-13
|
|
2011
|
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation.
|
Madureira ABM, Eapen M, Teira P, Zhang MJ, Davies SM, Picardi A, Woolfrey A, Chan KW, Socie G, Vora A, Bertrand Y, Sales-Bonfim CM, Gluckman E, Niemeyer C, Rocha V
|
Leukemia 25:449-454
|
|
2011
|
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries.
|
Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS
|
Bone Marrow Transplantation 46:70-76
|
|
2011
|
Similar outcomes using myeloablative versus reduced intensity allogeneic transplant preparative regimens for AML or MDS.
|
Luger SM, Ringdén O, Zhang M-J, Pérez WS, Bishop MR, Bornhauser M, Bredeson CN, Cairo MS, Copelan EA, Gale RP, Giralt SA, Gulbas Z, Gupta V, Hale GA, Lazarus HM, Lewis VA, Lill MC, McCarthy PL, Weisdorf DJ, Pulsipher MA
|
Bone Marrow Transplantation
|
|
2011
|
Comparison of reduced-intensity allogeneic hematopoietic cell transplantation with chemotherapy in patients aged 60-70 years with acute myeloid leukemia in first remission: a center for international blood and marrow transplant research and cancer and leukemia group b study.
|
Farag SS, Maharry K, Zhang MJ, Pérez WS, George SL, Mrózek K, DiPersio J, Bunjes DW, Marcucci G, Baer MR, Cairo M, Copelan E, Cutler CS, Isola L, Lazarus HM, Litzow MR, Marks DI, Ringdén O, Rizzieri DA, Soiffer R, Larson RA, Tallman MS, Bloomfield CD, Weisdorf DJ
|
Biology of Blood & Marrow Transplantation 17:1796-1803
|
|
2011
|
Classifying cytogenetics in patients with aml in complete remission undergoing allogeneic transplantation: a CIBMTR study.
|
Armand P, Kim HT, Zhang MJ, Pérez WS, Cin PD, Klumpp TR, Lazarus HM, Artz AS, Gupta V, Isola LM, Halter J, Rowe JM, Antin JH, Camitta BM, Cairo MS, Sierra JG, Stiff PJ, Nabhan C, Jakubowski AA, Devine SM, Maziarz RT, Marks DI, Aljurf MD, Soiffer RJ, Weisdorf DJ
|
Biology of Blood & Marrow Transplantation 18:280-288
|
|
2011
|
Prognostic factors for outcomes in allogeneic transplantation for chronic myeloid leukemia in the imatinib era: a CIBMTR analysis.
|
Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A, Gale RP, Marks DI, McCarthy PL, Woolfrey AE, Szer J, Giralt SA, Maziarz RT, Cortes J, Horowitz MM, Lee SJ
|
Bone Marrow Transplantation
|
|
2011
|
Donor characteristics affecting graft failure and survival after unrelated donor transplantation with reduced intensity conditioning for hematologic malignancies.
|
Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks D, Gratwohl A, Eapen M
|
Biology of Blood & Marrow Transplantation 17:1869-1873
|
|
2011
|
Impact of immune modulation with anti-T cell antibodies on the outcome of reduced intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
|
Soiffer RJ, LeRademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M
|
Blood 117:6963-6970
|
|
2011
|
Risk factors for acute GvHD and survival after hematopoietic cell transplantation.
|
Jagasia MH, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson CN, Cahn JY, Cairo MS, Gale RP, Gupta V, Lee SJ, Litzow MR, Weisdorf DJ, Horowitz MM, Hahn T
|
Blood 119:296-307
|
|
2011
|
Risk factors associated with increased non-relapse mortality and with poor overall survival in children with chronic graft-versus-host disease.
|
Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MC, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ
|
Blood 118:4472-4479
|
|
2011
|
Chronic GVHD Risk Score: A Center for International Blood and Marrow Transplant Research Analysis
|
Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola LM, Jacobsohn DA, Jagasia MH, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Wingard JR, Horowitz MM, Pavletic SZ
|
Blood
|
|
2011
|
Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes.
|
Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst RE, Kurtzberg J, Lazarus HM, LeMaistre CF, McCarthy PL, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, Majhail NS
|
Biology of Blood & Marrow Transplantation
|
|
2011
|
Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared to children and older adults with acute myeloid leukemia
|
Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM
|
Biology of Blood & Marrow Transplantation
|
|
2011
|
Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results.
|
Howard D, Kenline C, Gajewski JL, Hale GA, Hassebroek A, Hayes-Lattin BM, Horowitz MM, Lazarus HM, LeMaistre CF, Maziarz RT, McCarthy PL, Parsons SK, Rizzo JD, Szwajcer D, Majhail NS
|
Health Services Research
|
|
2011
|
Malignancies after hematopoietic cell transplantation for primary immune deficiencies: A report from the CIBMTR.
|
Kamani NR, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, Cowan M, Sánchez de Toledo J, Ferster A, Szabolcs P, Wingard JR, Horwitz E, Filipovich AH
|
Biology of Blood & Marrow Transplantation 17:1783-1789
|
|
2011
|
Clinical outcomes following hematopoietic stem cell transplantation for the treatment of Mucopolysaccharidosis VI.
|
Turbeville S, Nicely H, Rizzo JD, Pedersen TL, Orchard PJ, Horwitz ME, Horwitz EM, Veys P, Bonfim C, Al-Seraihy A
|
Molecular Genetics and Metabolism 102:111-115
|
|
2011
|
One antigen mismatched related vs. HLA-matched unrelated donor hematopoietic transplantation in adults with acute leukemia: CIBMTR results in the era of molecular HLA typing.
|
Valcarcel D, Sierra J, Wang T, Kan F, Gupta V, Hale GA, Marks DI, McCarthy PL, Oudshoorn M, Petersdorf EW, Ringden O, Setterholm M, Spellman SR, Waller EK, Gajewski JL, Marino SR, Senitzer D, Lee SJ
|
Biology of Blood & Marrow Transplantation 17:640-648
|
|
2011
|
HLA-C antigen mismatches are associated with worse outcomes in unrelated donor peripheral blood stem cell transplantation.
|
Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M, Gajewski J, Hale GA, Horan J, Battiwalla M, SR Marino, Setterholm M, Ringden O, Hurley C, Flomenberg N, Anasetti C, Fernandez-Vina M, Lee SJ
|
Biology of Blood & Marrow Transplantation 17:885-892
|
|
2011
|
Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation.
|
Marino SR, Lin S, Maiers M, Haagerson M, Spellman S, Klein JP, Binkowski TA, Lee SJ, van Besien K
|
Bone Marrow Transplantation
|
|
2011
|
Scoring HLA Class I Mismatches by HistoCheck Does Not Predict Clinical Outcome in Unrelated Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation.
|
Spellman SR, Klein JP, Haagenson MD, Askar M, Baxter-Lowe LA, He J, Hsu S, Blasczyk R, Hurley CK
|
Biology of Blood & Marrow Transplantation
|
|
2011
|
No increased mortality from donor or recipient hepatitis B and/or hepatitis C positive serostatus after related donor allogeneic hematopoietic cell transplantation.
|
Tomblyn MR, Kukreja M, Tarima S, Aljurf MD, Al Mohareb FI, Bolwell BJ, Cahn JY, Carabasi MH, Gale RP, Gress RE, Gupta V, Hale GA, Ljungman P, Maziarz RT, Storek J, Wingard JR, Young JH, Horowitz MM, Ballen KK
|
Transplant Infectious Disease
|
|
2011
|
An international comparison of current strategies to prevent herpes virus and fungal infections in hematopoietic cell transplant recipients.
|
Pollack M, Heugel J, Xie H, Leisenring W, Storek J, Young JA, Kukreja M, Gress R, Tomblyn M, Boeckh M
|
Biology of Blood & Marrow Transplantation 17:664-673
|
|
2011
|
High probability of long-term survival in 2 year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.
|
Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD
|
Bone Marrow Transplantation 46:385-392
|
|
2011
|
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation
|
Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socie G
|
Journal of Clinical Oncology 29:2230-2239
|
|
2011
|
Pregnancy after hematopoietic-cell transplantation: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR)
|
Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley JF, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin BM, Maziarz RT, Warwick AB, Sor
|
Biology of Blood & Marrow Transplantation 17:157-166
|
|
2011
|
Secondary solid cancers after allogeneic hematopoietic cell transplantation using Busulfan-cyclophosphamide conditioning.
|
Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G
|
Blood 117:316-322
|
|
2011
|
Outcome of lower-intensity allogeneic transplantation for non-Hodgkin lymphoma relapsing after autologous transplantation.
|
Freytes CO, Zhang MJ, Carreras J, Burns LJ, Gale RP, Isola LM, Perales MA, Seftel M, Vose JM, Miller AM, Gibson J, Gross TG, Rowlings PA, Inwards DJ, Pavlovsky S, Martino R, Marks DI, Hale GA, Smith SM, Schouten HC, Slavin S, Klumpp TR, Lazarus HM, Van Besien KM, Hari PN
|
Biology of Blood & Marrow Transplantation
|
|
2011
|
HLA-matched sibling bone marrow transplantation for ß-Thalassemia major
|
Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC
|
Blood 117:1745-1750
|
|
2011
|
Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.
|
Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang MJ, Horn BN, Margolis DA, Perentesis JP, Sanders JE, Schultz KR, Seber A, Woods WG, Eapen M
|
Biology of Blood & Marrow Transplantation 17:723-728
|
|
2011
|
Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.
|
Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo MS, Dvorak C, Duval M, Davies S, Eapen M, Gross TG, Hussein AA, MacMillan ML, Mehta PA, Pulsipher MA, Seber A, Woolfrey AE, Frangoul HA, Carpenter PA
|
Biology of Blood & Marrow Transplantation 17:1833-1840
|
|
2011
|
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
|
Ringdén O, Shrestha S, Tunes da Silva G, Zhang MJ, Dispenzieri A, Remberger M, Kamble RT, Freytes CO, Gale RP, Gibson J, Gupta V, Holmberg LA, Lazarus HM, McCarthy PL, Meehan KR, Schouten HC, Milone GA, Lonial S, Hari PN
|
Bone Marrow Transplantation
|
|
2011
|
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma
|
Vogl DT, Wang T, Pérez WS, Stadtmauer EA, Heitjan DF, Lazarus HM, Kyle RA, Kamble R, Weisdorf D, Gibson J, Ballen K, Holmberg L, Bashey A, McCarthy PL, Freytes C, Maharaj D, Maiolino A, Vesole DH, Hari P
|
Biology of Blood & Marrow Transplantation 17:1765-1774
|
|
2011
|
Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia
|
Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC
|
Biology of Blood & Marrow Transplantation 17:737-744
|
|
2011
|
Reducing the risk for transplant related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
|
Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC
|
Journal of Clinical Oncology 29:805-813
|
|
2011
|
Low Risk of Chronic Graft Versus Host Disease and Relapse Associated with T-Cell Depleted Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303
|
Devine SM, Carter S, Soiffer RJ, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Stadtmauer EA, Alyea EP III, Keever-Taylor CA, O'Reilly RJ
|
Biology of Blood & Marrow Transplantation 17:1343-1351
|
|
2011
|
Comparative analysis of Busulfan and Cyclophosphamide versus Cyclophosphamide and total body irradiation in full intensity unrelated marrow donor transplantation for acute myelogenous leukemia, chronic myelogenous leukemia and myelodysplasia.
|
Uberti JP, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman C, McCarthy PL, Ratanatharathorn V, Ringden O, Weisdorf DJ, Rizzo JD
|
Bone Marrow Transplantation 46:34-43
|
|
|